These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 3184579

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Study of the Thomsen-Friedenreich antigen in bladder tumors].
    Fukatsu H, Yamada H, Nonomura H, Miyagawa Y, Waki M, Hatano Y, Hiraiwa S, Muramatsu T, Nishikawa E, Yamada Y.
    Hinyokika Kiyo; 1988 Feb; 34(2):260-7. PubMed ID: 3376818
    [Abstract] [Full Text] [Related]

  • 3. [Prognostic factors for progression of superficial bladder cancer].
    Sato N, Sumiya H, Isaka S, Shimazaki J, Matsuzaki O.
    Nihon Hinyokika Gakkai Zasshi; 1992 Aug; 83(8):1263-9. PubMed ID: 1405165
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tissue blood group ABH and Thomsen-Friedenreich antigens in human urinary bladder carcinoma.
    Weinstein RS, Miller AW, Coon JS.
    Prog Clin Biol Res; 1984 Aug; 153():249-60. PubMed ID: 6382282
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prognosis in carcinoma of the urinary bladder based upon tissue blood group abh and Thomsen-Friedenreich antigen status and karyotype of the initial tumor.
    Summers JL, Coon JS, Ward RM, Falor WH, Miller AW, Weinstein RS.
    Cancer Res; 1983 Feb; 43(2):934-9. PubMed ID: 6848204
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [The study of cell surface antigens in bladder tumors: ABH-isoantigen and Thomsen-Friedenreich antigen].
    Kobayashi H.
    Hinyokika Kiyo; 1987 Apr; 33(4):535-44. PubMed ID: 3618425
    [Abstract] [Full Text] [Related]

  • 12. Blood group ABH-related antigens in normal and malignant bladder urothelium: possible structural basis for the deletion of type-2 chain ABH antigens in invasive carcinomas.
    Orntoft TF, Wolf H, Clausen H, Dabelsteen E, Hakomori S.
    Int J Cancer; 1989 May 15; 43(5):774-80. PubMed ID: 2497072
    [Abstract] [Full Text] [Related]

  • 13. The study on cell surface antigens in epithelial tumor of the upper urinary tract: ABH-isoantigen and Thomsen-Friedenreich antigen.
    Fukatsu H, Nonomura H, Miyagawa Y, Waki M, Hatano Y, Hiraiwa S, Muramatsu T, Nishikawa E, Yamada Y, Satoh T.
    Hinyokika Kiyo; 1989 Jun 15; 35(6):949-54. PubMed ID: 2801395
    [Abstract] [Full Text] [Related]

  • 14. Molecular markers in the diagnosis and prognosis of bladder cancer.
    Lange PH, Limas C.
    Urology; 1984 Apr 15; 23(4 Suppl):46-54. PubMed ID: 6369720
    [No Abstract] [Full Text] [Related]

  • 15. [Prognostic markers in transitional carcinoma of the bladder].
    Blasco E, Gutiérrez-Hoyos A, Garrido C, Arozena F.
    Arch Esp Urol; 1991 Apr 15; 44(1):47-52. PubMed ID: 2064423
    [Abstract] [Full Text] [Related]

  • 16. T-antigen in normal and neoplastic urothelium.
    Limas C, Lange P.
    Cancer; 1986 Sep 15; 58(6):1236-45. PubMed ID: 3742450
    [Abstract] [Full Text] [Related]

  • 17. Flow cytometric evaluation of Thomsen-Friedenreich antigen on transitional cell cancer using monoclonal antibody.
    Oda H, Oda T, Ohoka H, Yokoyama M, Takeuchi M.
    Urol Res; 1990 Sep 15; 18(2):107-11. PubMed ID: 2339479
    [Abstract] [Full Text] [Related]

  • 18. Monoclonal antibodies to detect A, B and H blood group isoantigens in superficial transitional cell carcinoma of the bladder: a means of predicting invasive recurrences.
    Stephenson TJ, Williams JL, Gelsthorpe K.
    Br J Urol; 1985 Apr 15; 57(2):148-53. PubMed ID: 3886066
    [Abstract] [Full Text] [Related]

  • 19. Thomsen-Friedenreich antigen in bladder tumors as detected by specific antibody: a possible marker of recurrence.
    Ohoka H, Shinomiya H, Yokoyama M, Ochi K, Takeuchi M, Utsumi S.
    Urol Res; 1985 Apr 15; 13(2):47-50. PubMed ID: 4012935
    [Abstract] [Full Text] [Related]

  • 20. [Determination of surface ABO(H) isoantigens in transitional cell carcinoma of the bladder. Clinicopathological study. (Part 1)].
    Gelabert Mas A, Corominas J, Arango O.
    Actas Urol Esp; 1988 Apr 15; 12(3):248-53. PubMed ID: 3177059
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.